A feasibility randomized controlled trial of a NICU rehabilitation program for very low birth weight infants

Lisa Letzkus1,2, Mark Conaway3, Claiborne Miller-Davis4

  • 1Division of Developmental Pediatrics, Department of Pediatrics, University of Virginia, Charlottesville, VA, USA. lmc8c@virginia.edu.

Scientific Reports
|February 3, 2022
PubMed

Insights

The NeoRehab program, involving parents in preterm infant care, was acceptable and feasible for very low birthweight infants. A goal of 3 interventions per week, rather than 5, appears achievable for parents.

Area of Science:

  • Neonatal care
  • Developmental pediatrics
  • Rehabilitation medicine

Background:

  • Motor disabilities are common in preterm infants.
  • Parental involvement in NICU care can improve outcomes.
  • The NeoRehab program offers sensory and motor interventions by parents.

Purpose of the Study:

  • To assess the acceptability, feasibility, and fidelity of the NeoRehab program.
  • To evaluate parent engagement with NeoRehab interventions for VLBW infants.
  • To determine optimal dosing for parent-delivered interventions in NICU settings.

Main Methods:

  • A randomized controlled trial compared NeoRehab to usual care in VLBW infants (≤32 weeks GA or ≤1500g).
  • Parents delivered interventions 5 days/week as the goal.
  • Acceptability, feasibility, and fidelity were primary outcomes.

Main Results:

  • Recruitment was 71%, retention 98%.
  • No infants met the 5-day/week goal, but 97% performed interventions ≥3 times/week.
  • The program was acceptable to parents; motor interventions were most challenging.

Conclusions:

  • The NeoRehab program is acceptable and feasible for parents of VLBW infants.
  • A goal of 3 interventions/week is feasible in the US, unlike 5 days/week.
  • Future studies should explore alternative strategies for motor interventions and dosing impact on long-term outcomes.

Related Concept Videos